ACRIVON THERAPEUTICS INC (ACRV:NASDAQ)

$2.07 -0.02 (-0.9569%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 84

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed ACRIVON THERAPEUTICS INC (ACRV:NASDAQ) News Sources

Acrivon Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

19-03-2026

yahoo.com

Acrivon Reports First Quarter 2026 Financial Results and Highlights Progress Towards Key 2026 Clinical Catalysts

13-05-2026

yahoo.com

Acrivon Advances ACR-2316, a Potential First-in-Class WEE1/PKMYT1 Inhibitor, into Randomized Dose Expansion in its Ongoing Phase 1/2 Study

05-08-2026

yahoo.com

Acrivon Reports Second Quarter 2026 Financial Results and Highlights Upcoming 2026 Clinical Data Catalysts

12-08-2026

yahoo.com

Acrivon to Highlight Preclinical Data with Three Posters at AACR Demonstrating Strong ACR-368 and ACR-2316 Synergies with Immune Checkpoint Inhibitors and ADC Payloads, Revealing Broad Clinical Development Opportunities

17-04-2026

yahoo.com

Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

15-05-2026

yahoo.com

Acrivon Therapeutics to Present at TD Cowen’s 7th Annual Oncology Innovation Summit

21-05-2026

yahoo.com

Acrivon to Highlight the Power of its AP3 Platform for Streamlined, Pathway-Based Drug Discovery and Development with Oral and Poster Presentations at AACR D3 Conference

21-07-2026

yahoo.com

Here's Why Acrivon Therapeutics, Inc. (ACRV) is a Great Momentum Stock to Buy

24-08-2026

yahoo.com

Acrivon Therapeutics Appoints Michaela Levin, Ph.D., as Chief Business Officer

31-08-2026

yahoo.com

ACRIVON THERAPEUTICS INC (ACRV:NASDAQ) Sentiment Trend

0 25 50 75 100 70 86 87 89 81 82 90 85 92 81 19-03-2026 13-05-2026 05-08-2026 12-08-2026 17-04-2026 15-05-2026 21-05-2026 21-07-2026 24-08-2026 31-08-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

ACRIVON THERAPEUTICS INC (ACRV:NASDAQ) FAQs

toggle

What is the current price of ACRIVON THERAPEUTICS INC (ACRV:NASDAQ)?

The current price of ACRIVON THERAPEUTICS INC (ACRV:NASDAQ) is $2.07.


toggle

ACRIVON THERAPEUTICS INC (ACRV:NASDAQ) absolute price change since previous trading day?

The absolute price change of ACRIVON THERAPEUTICS INC (ACRV:NASDAQ) since the previous trading day is $-0.02.


toggle

ACRIVON THERAPEUTICS INC (ACRV:NASDAQ) percentage price change since previous trading day?

The percentage price change of ACRIVON THERAPEUTICS INC (ACRV:NASDAQ) since the previous trading day is -0.9569%.


toggle

What is the most recent average sentiment score for ACRIVON THERAPEUTICS INC (ACRV:NASDAQ)?

The most recent average sentiment score for ACRIVON THERAPEUTICS INC (ACRV:NASDAQ) is 84 out of 100.


toggle

What is the most recent average sentiment for ACRIVON THERAPEUTICS INC (ACRV:NASDAQ)?

The most recent sentiment for ACRIVON THERAPEUTICS INC (ACRV:NASDAQ) is .


SEC-8K** Filing Available For ACRIVON THERAPEUTICS INC (ACRV:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.